BioNexus Gene Lab
BGLC
#10233
Rank
NZ$8.89 M
Marketcap
$0.50
Share price
19.25%
Change (1 day)
-52.96%
Change (1 year)

BioNexus Gene Lab (BGLC) - Cash on Hand

Cash on Hand as of September 2024 : NZ$7.26 Million

According to BioNexus Gene Lab's latest financial reports the company has NZ$7.26 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioNexus Gene Lab - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$9.37 M180.94%
2022-12-31NZ$3.33 M7.33%
2021-12-31NZ$3.1 M-19.52%
2020-12-31NZ$3.86 M202.88%
2019-12-31NZ$1.27 M-32.11%
2018-12-31NZ$1.87 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.44 B 6,086.76%๐Ÿ‡บ๐Ÿ‡ธ USA